On June 5th, Gelonhui reported that Ruian Gene (688217.SH) announced that its wholly-owned subsidiary, Suzhou Yuntai Biomedical Technology Co., Ltd., obtained the "Medical Device Registration Certificate (In Vitro Diagnostic Reagent)" issued by the National Medical Products Administration for its BCR-ABL P210 Fusion Gene Detection Test Kit (Fluorescent RT-PCR Method) recently. The approval of the Medical Device Registration Certificate for the BCR-ABL P210 fusion gene detection test kit (fluorescent RT-PCR method) is another important breakthrough for Ruian Gene in the field of leukemia detection.
睿昂基因(688217.SH)：BCR-ABL P210融合基因检测试剂盒获得医疗器械注册证
Ruiang Gene (688217.SH): BCR-ABL P210 Fusion Gene Detection Kit has obtained the registration certificate for medical instruments.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.